# Benign Prostatic Hyperplasia

This is a subcategory of Genitourinary Agents.

## Formulary

### Preferred

| Preferred             |
| :-------------------- |
| Alfuzosin             |
| Doxazosin             |
| Dutasteride           |
| Finasteride           |
| Prazosin              |
| Tadalafil PA 2.5, 5mg |
| Tamsulosin            |
| Terazosin             |

### Non-Preferred

| Non-Preferred          |
| :--------------------- |
| Cardura XL             |
| Dutasteride/Tamsulosin |
| Silodosin              |

## Length of Authorizations

365 Days

## Prior Authorization Criteria

1.  Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:
    1.  Allergy to medications not requiring prior approval
    2.  Contraindications to or drug interaction with medications not requiring prior approval
    3.  History of unacceptable/toxic side effects to medications not requiring prior approval
2.  Patient must have a therapeutic failure to no less than a **30-day** trial on at least **two** medications that are preferred.

## Additional Criteria
### Tadalafil (CIALIS)

Additional Criteria for Approval of Tadalafil (CIALIS)

Patient must have diagnosis of benign prostatic hyperplasia and have a therapeutic failure to no less than a 30-day trial on at least one alpha-1 adrenergic blocker and a 90-day trial of finasteride.

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=68)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=24)
